LogicMark(LGMK) - 2025 Q4 - Annual Results

Financial Performance - Fourth-quarter revenue increased 36% to $3.1 million, while full-year revenue rose 15% to $11.4 million[5] - Gross margin for the fourth quarter improved to 69.8%, up from 66.3% in the prior-year period, and full-year gross margin remained strong at 66.8%[12][16] - Full-year gross profit improved 15% to $7.6 million, driven by higher sales volume, particularly to the Veterans Health Administration[16] - Revenues for Q4 2025 reached $3,065,348, a 36.3% increase from $2,249,174 in Q4 2024[27] - Gross Profit for the year ended December 31, 2025, was $7,630,601, up 15.3% from $6,615,993 in 2024[27] - Net Loss for the year ended December 31, 2025, was $(7,467,427), a decrease of 17.1% compared to $(9,003,745) in 2024[27] - Basic and Diluted Net Loss per Share for Q4 2025 was $(1.96), compared to $(1,349.73) in Q4 2024, indicating a substantial reduction in loss per share[27] Operating Expenses - Operating expenses for the fourth quarter were $3.8 million, a 3% increase from the prior-year period, while full-year operating expenses rose by approximately 9% to $15.5 million[13][17] - Total Operating Expenses for the year 2025 were $15,529,893, compared to $14,286,724 in 2024, indicating a rise in operational costs[27] - Research and Development expenses increased to $617,369 for the year 2025, up from $558,621 in 2024, reflecting a focus on innovation[27] Cash and Assets - Cash and investments totaled $9.5 million at December 31, 2025, with no long-term debt reported[15] - The company reported total assets of $20.3 million as of December 31, 2025, compared to $14.2 million in the prior year[24] Strategic Initiatives - The company plans to launch a wearable watch in Q3 2026 and is beta testing a connected-home hub for proactive care[8] - LogicMark is expanding distribution across healthcare, government, B2B, and consumer channels, supported by a renewed five-year GSA contract[7] - LogicMark's strategy includes moving from reactive alerting to proactive, predictive care through AI and IoT technologies[5] Other Financial Metrics - The net loss for the fourth quarter was $1.6 million, an improvement from a net loss of $3.7 million in the prior-year period[14] - Operating Loss for Q4 2025 was $(1,669,181), an improvement from $(2,194,513) in Q4 2024[27] - Interest income for Q4 2025 was $79,867, significantly higher than $26,378 in Q4 2024, showing improved financial management[27] - Total Other Income (Expense), Net for the year 2025 was $446,718, a recovery from $(1,323,068) in 2024[27] - Preferred stock dividends remained constant at $(75,000) for both Q4 2025 and Q4 2024, indicating stable dividend policy[27]